Parameter | Group | P-val. | ||
---|---|---|---|---|
T&I | VIT | |||
Age (year) | Mean ± SD | 64 ± 11 | 66 ± 8 | 0.524† |
Median (range) | 64 (38 to 88) | 64 (51 to 80) | ||
Onset time (day) | Mean ± SD | 6.7 ± 3.5 | 5.2 ± 2.3 | 0.202‡ |
Median (range) | 5 (2 to 15) | 5 (3 to 10) | ||
Gender | Male | 27 (50.9%) | 13 (56.5%) | 0.655* |
Female | 26 (49.1%) | 10 (43.5%) | ||
Diabetes mellitus | Positive | 17 (32.1%) | 9 (39.1%) | 0.551* |
Negative | 36 (67.9%) | 14 (60.9%) | ||
Hypertension | Positive | 17 (32.1%) | 9 (39.1%) | 0.551* |
Negative | 36 (67.9%) | 14 (60.9%) | ||
Culture | Negative | 28 (52.8%) | 8 (34.8%) | 0.021** |
Staphylococcus epidermidis | 23 (43.4%) | 9 (39.1%) | ||
Staphylococcus aureus | 2 (3.8%) | 5 (21.7%) | ||
Streptococcus pneumoniae | 0 (0.0%) | 1 (4.3%) | ||
Complication | Negative | 49 (92.5%) | 23 (100.0%) | > 0.99** |
Retinal detachment | 1 (1.9%) | 0 (0.0%) | ||
Pseudophakik bullous keratopathy | 2 (3.8%) | 0 (0.0%) | ||
Necrotizing scleritis | 1 (1.9%) | 0 (0.0%) | ||
Secondary vitrectomy | Negative | 32 (60.3%) | 22 (95.6%) | 0.042** |
Secondary vitrectomy | 21 (39.6%) | 1 (4.3%) |